Background. Immunoadsorption is increasingly used to treat antibody-mediated autoimmune diseases. To prevent microbial growth during storage, reusable protein A-Sepharose gel columns are primed with ethyl mercury thiosalicylate (thiomersal, 0.1% solution) and rinsed with phosphate buffer before use.
Introduction
Immunoadsorption is a novel adsorption technique for semi-selective extracorporeal removal of circulating autoantibodies in disorders such as recurrent kidney graft rejection due to HLA hypersensitization [1], renal autoimmune disorders [2], haemophilia with inhibitors to factor VIII or IX [3] , congestive heart failure [4] and neurological autoimmune diseases including myasthenia gravis and Guillain-Barre syndrome [5] . Current apheresis systems employ reusable columns designed for long-term storage (20-50 treatment sessions). To prevent microbial growth, staphylococcal protein ASepharose (PA) columns are primed with ethyl mercury thiosalicylic acid (buffered thiomersal 0.1% solution) during storage and rinsed with phosphate buffer before use [6] . In contrast, anti-IgG immunoadsorbers are stored after priming with phosphate-buffered saline (PBS)-sodium azide [7] .
The long half-life of ethylmercury could theoretically result in accumulation and toxicity during chronic application, as discussed in the context of thiomersalcontaining vaccines [8] . Following recommendations from the US Public Health Service and the American Academy of Pediatrics, thiomersal has been largely replaced in infant vaccines, although no clear evidence of potential health and development problems has been demonstrated so far [8] . Organic mercury toxicity affects mainly the central nervous system (CNS), with symptoms such as lethargy, loss of appetite, weight loss, tremor, memory loss, sleep disturbance, emotional lability and confusion [9] . Furthermore, mercury may cause significant damage to the haematopoietic and renal system [9] . Since PA immunoadsorption has been used successfully for several years at our department, the lack of long-term safety data led us to investigate the hypothesis of a thiomersal-related mercury release during apheresis.
